Publication:
Current status of bone regeneration using adipose-derived stem cells

Thumbnail Image
Files
Tajima-33-619-627-2018.pdf(2.24 MB)
Date
2018
relationships.isAuthorOfPublication
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Tajima, Satoshi ; Tobita, Morikuni ; Mizuno, Hiroshi
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia. Departamento de BiologĂ­a Celular e HistologĂ­a
publication.page.editor
publication.page.department
DOI
DOI: 10.14670/HH-11-942
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Many bone regeneration therapies have been developed for clinical use and have variable outcomes and serious limitations. The goal of bone regeneration is to repair a bone defect in a stable and durable manner. Cellular strategies play an important role in bone tissue engineering. Clinical factors important for successful bone regeneration are the recruitment of cells to the defect site and the production of a suitable extracellular matrix consistent with bone tissues. Adipose-derived stem cells (ASCs) can be obtained in large quantities with little donor site morbidity or patient discomfort. They are multipotent somatic stem cells and have a strong potential to differentiate and secrete growth factors. In this review, we discuss the osteogenic potential of ASCs with/without several types of scaffolds in vivo and their clinical application for bone regeneration.
publication.page.subject
Bone regeneration , Adipose-derived stem cells
Citation
Histology and Histopathology, Vol.33, nÂş7, (2018)
URI
http://hdl.handle.net/10201/119589
item.page.embargo
Collections
Histology and histopathology Vol.33, nÂş7 (2018)
Ir a EstadĂ­sticas